Your Location:
Home >
Browse articles >
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
Excellent effects and possible mechanisms of action of a new antibody–drug conjugate against EGFR-positive triple-negative breast cancer
- Military Medical Research Vol. 9, Issue 4, Pages: 419-431(2022)
DOI: 10.1186/s40779-021-00358-9
Scan QR Code
Full Text(HTML)
Figs( 7 ) Tabs( 0 )
References
Publication Info
Metrics
14
Views
22
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer
Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases
Engineering of functional auditory neurons from human induced pluripotent stem cells
Related Author
Liu Chen
Rong-Rong Zhou
Paul R Lockman
Thomas Michael Marti
Hai-Bin Deng
Mu-Yuan Jia
Jie Yang
Ke-Qin Zhang
Related Institution
Department of Radiation Oncology, Hunan Cancer Hospital/Affiliated Hospital of Xiangya School of Medicine, Central South University
Xiangya Lung Cancer Center, Xiangya Hospital, Central South University
Department of Neuroscience, West Virginia University School of Medicine, Rockefeller Neuroscience Institute
Department of Pharmaceutical Sciences, West Virginia University School of Pharmacy
Department for BioMedical Research, University of Bern

